Balance Sheet
Cash Flow Statement
AmortizationBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Free Cash Flow (2024 - 2025)

Historic Free Cash Flow for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to -$83.3 million.

  • Abivax's Free Cash Flow fell 11638.14% to -$83.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$193.1 million, marking a year-over-year decrease of 4817.93%. This contributed to the annual value of -$165.3 million for FY2024, which is 5692.3% down from last year.
  • Per Abivax's latest filing, its Free Cash Flow stood at -$83.3 million for Q3 2025, which was down 11638.14% from -$37.7 million recorded in Q2 2025.
  • In the past 5 years, Abivax's Free Cash Flow registered a high of -$35.0 million during Q1 2025, and its lowest value of -$83.3 million during Q3 2025.